Oral inoculation with Type III secretion mutants of Yersinia pseudotuberculosis provides protection from oral, intraperitoneal, or intranasal challenge with virulent Yersinia

被引:13
作者
Balada-Llasat, Joan-Miquel
Panilaitis, Bruce
Kaplan, David
Mecsas, Joan
机构
[1] Tufts Univ, Dept Microbiol & Mol Biol, Boston, MA 02111 USA
[2] Tufts Univ, Dept Biomed Engn, Bioengn & Biotechnol Ctr, Medford, MA 02155 USA
关键词
Yersinia; type III secretion system; live attenuated;
D O I
10.1016/j.vaccine.2006.10.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The enteric pathogen Yersinia pseudotuberculosis (Yptb) causes gastroenteritis, mesentetic lymphadenitis, and systemic infections in humans, livestock, and wild animals. Yptb Type III secretion system (pTTSS) mutants efficiently colonize lymphoid tissues, but not the gastrointestinal tract, spleen, or liver. Here, we show that a single oral inoculation of pTTSS mutants prevents morbidity in almost 100% of mice challenged intragastrically with virulent Yptb. In addition, a single oral inoculation of a pTTSS mutant protected 50% of mice challenged intraperitoneally or intranasally with virulent Yptb. In addition, the intranasally challenged mice that succumbed to infection lived significantly longer than non-immunized mice. Thus, pTTSS mutants can function as live attenuated vaccine when delivered orally. Potential uses for these attenuated strains include use as a livestock vaccine, a rodent plague control reagent in endemic areas around the world, and a vector for delivery of other antigens to the mesenteric lymph nodes. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1526 / 1533
页数:8
相关论文
共 34 条
[1]   Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis [J].
Achtman, M ;
Zurth, K ;
Morelli, C ;
Torrea, G ;
Guiyoule, A ;
Carniel, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) :14043-14048
[2]   Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis [J].
Andrews, GP ;
Strachan, ST ;
Benner, GE ;
Sample, AK ;
Anderson, GW ;
Adamovicz, JJ ;
Welkos, SL ;
Pullen, JK ;
Friedlander, AM .
INFECTION AND IMMUNITY, 1999, 67 (03) :1533-1537
[3]  
BALADALLASAT JM, 2006, PLOS PATHOG, V2
[4]   ROLE OF THE YADA-PROTEIN IN PREVENTION OF OPSONIZATION OF YERSINIA-ENTEROCOLITICA BY C3B MOLECULES [J].
CHINA, B ;
SORY, MP ;
NGUYEN, BT ;
DEBRUYERE, M ;
CORNELIS, GR .
INFECTION AND IMMUNITY, 1993, 61 (08) :3129-3136
[5]  
Cornelis GR, 2002, INT J MED MICROBIOL, V291, P455
[6]   YERSINIA-ENTEROCOLITICA [J].
COVER, TL ;
ABER, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (01) :16-24
[7]  
FRIESEN HG, 1995, MRC COMMUNIQUE, V21, P2
[8]   ACUTE MESENTERIC LYMPHADENITIS DUE TO YERSINIA-PSEUDOTUBERCULOSIS LACKING A VIRULENCE PLASMID [J].
FUKUSHIMA, H ;
SATO, T ;
NAGASAKO, R ;
TAKEDA, I .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (06) :1271-1275
[9]  
FUKUSHIMA H, 1991, ZBL BAKT-INT J MED M, V275, P530
[10]   Yersinia enterocolitica O9 as a possible barrier against Y. pestis in natural plague foci in Ningxia, China [J].
Fukushima, H ;
Hao, Q ;
Wu, KL ;
Hu, X ;
Chen, JH ;
Guo, ZF ;
Dai, HX ;
Qin, CY ;
Lu, SD ;
Gomyoda, M .
CURRENT MICROBIOLOGY, 2001, 42 (01) :1-7